News Articles on 'Renal Medicine'

Back to All Specialties


Clinical Medicine student offers to sell kidney to raise college fees

Michael Muruthi Wanjohi, a second year student pursuing a diploma in clinical medicine and surgery at Kenya Medical Training College, Embu Campus. [Joseph Muchiri/Standard] A student at the Kenya Medical Training College, Embu Campus has put up his kidney ...

Source: standardmedia.co.ke
Published: 18 Feb 2019

Drug combinations could become first-line treatment for metastatic kidney cancer

Choueiri, MD, senior and co-corresponding author of the report on the JAVELIN Renal 101 trial in the New England Journal of Medicine and Director of the Lank Center for Genitourinary Oncology at Dana-Farber. "This is certainly better than sunitinib ...

Source: News Medical
Published: 18 Feb 2019

Drug combination may become new standard treatment for advanced kidney cancer

Choueiri, MD, senior and co-corresponding author of the report on the JAVELIN Renal 101 trial in the New England Journal of Medicine and Director of the Lank Center for Genitourinary Oncology at ...

Source: Medical Xpress
Published: 17 Feb 2019

Merck, Pfizer drug combo extends kidney cancer survival: study

A similar kidney cancer trial pitting Sutent against a combination ... s Gustave Roussy Cancer Campus said in an editorial in the New England Journal of Medicine. Immunotherapies help the immune system to recognize and attack cancer. Inlyta is a newer ...

Source: Reuters
Published: 17 Feb 2019

Drug combo may help treat advanced kidney cancer

The study, published in the New England Journal of Medicine, to combine avelumab with a drug that ... The clinical trial involved 886 patients with previously untreated, advanced renal cell carcinoma who were randomised to receive the drug combination ...

Source: India
Published: 18 Feb 2019

Grow your own kidney? Chicago researchers are getting closer

Wertheim’s Northwestern team works closely with the University of Chicago’s Institute for Molecular Engineering to advance kidney regenerative medicine. The two universities have a shared grant through the Chicago Biomedical Consortium, which aims to ...

Source: Crain's Chicago Business
Published: 13 Feb 2019

Immunotherapies could change kidney cancer care, studies suggest

The way doctors typically approach kidney cancer treatment could be evolving. Two separate studies published Saturday in the New England Journal of Medicine showed that renal cell cancer patients had significantly better outcomes when their treatment ...

Source: KXLH
Published: 16 Feb 2019

Study Finds Low Statin Use Among Kidney Disease Patients at High Risk for Cardiovascular Disease

The study by researchers from Loyola Medicine, Loyola University Chicago and Hines VA Hospital was published in Clinical Kidney Journal. "Our findings suggest a need for education efforts to increase statin use in adults with non dialysis-dependent chronic ...

Source: Newswise
Published: 18 Feb 2019

NSAID Kidney Risk Underestimated in Young, Active Adults

The risks of incident and chronic renal disease associated with regular use of nonsteroidal ... Alan Nelson, MPAS, PhD, of the Division of Primary Care and Population Health in the Department of Medicine at Stanford University, California, and colleagues.

Source: Medscape
Published: 15 Feb 2019

The disturbing hypothesis for the sudden uptick in chronic kidney disease

a kidney disease expert and professor of medicine at the University of Colorado. “The wards were filling up with people with chronic kidney disease or end-stage kidney failure, and these people didn’t have the typical causes of kidney failure,” like ...

Source: Vox
Published: 15 Feb 2019

Renal Anemia Treatment Market Will Reach at a CAGR of 7.5% Through 2026: Persistence Market Research

has recently received FDA approval for biosimilars for renal anemia. In December 2018, Roxadustat became the first approved oral HIF-PHI medicine in China for patients with anemia. It is ...

Source: Yahoo Finance
Published: 13 Feb 2019

New Therapy Is Found Effective in Kidney Cancer Test

More follow-up is needed to see whether the combination helps patients live longer, according to an editorial in the New England Journal of Medicine, which is publishing results from the so-called Javelin Renal 101 trial. The late-stage trial, which ...

Source: Bloomberg L.P.
Published: 17 Feb 2019

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

This phase 3 trial involving previously untreated patients with advanced renal-cell carcinoma compared avelumab plus ... Japan (M.U.); University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea (J.L.L.); Macquarie University, Sydney ...

Source: The New England Journal of Medicine
Published: 16 Feb 2019

Kidney Damage in Younger Adults Tied to NSAID Use

Kurina, PhD, of Stanford University School of Medicine in Stanford, California ... Hypertension, diabetes, rhabdomyolysis, and obesity significantly increased risks for kidney damage. Risks also increased with age. Both selective and nonselective NSAIDs ...

Source: Renal & Urology News
Published: 15 Feb 2019

ASCO GU 2019: Subgroup Analysis from JAVELIN Renal 101: Outcomes for Avelumab plus Axitinib versus Sunitinib in Advanced Renal Cell Carcinoma

In conclusion, JAVELIN Renal 101 demonstrated longer progression-free survival ... Of note, this practice changing data was also published in the New England Journal of Medicine.

Source: UroToday
Published: 18 Feb 2019

Chronic kidney disease is on the rise. These researchers think climate change is a factor.

a kidney disease expert and professor of medicine at the University of Colorado. “The wards were filling up with people with chronic kidney disease or end-stage kidney failure, and these people didn’t have the typical causes of kidney failure,” like ...

Source: Vox.com on MSN.com
Published: 15 Feb 2019

New Treatment May Be New Standard for Advanced Kidney Cancer

Choueiri, MD, senior and co-corresponding author of the report on the JAVELIN Renal 101 trial in the New England Journal of Medicine and Director of the Lank Center for Genitourinary Oncology at ...

Source: Interesting Engineering
Published: 18 Feb 2019

New Standard of Care for Metastatic Renal Cell Carcinoma

professor of medicine and urology at the University of Virginia School of Medicine in Charlottesville. "Metastatic kidney cancer has very low survival rates and there have been few significant advances in treating this advanced form of the disease," he said.

Source: Medscape
Published: 12 Feb 2019

Merck Gets Priority Review for Keytruda Combo in Kidney Cancer

In the latest sBLA, Merck is looking for FDA’s approval of Keytruda in combination with Pfizer’s PFE Inlyta for the first-line treatment of advanced or metastatic renal cell carcinoma (RCC ...

Source: Yahoo Finance
Published: 18 Feb 2019

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

The benefit of pembrolizumab plus axitinib was observed across the International Metastatic Renal Cell Carcinoma Database Consortium ... Tartas) — both in France; Military Institute of Medicine, Warsaw, Poland (C.S.); Rocky Mountain Cancer Center ...

Source: The New England Journal of Medicine
Published: 16 Feb 2019

Journal Highlight: Urinary proteomics and precision medicine for chronic kidney disease: Current status and future perspectives

Abstract: Precision medicine is since long an ongoing refinement of classical medicine, integrating improved and more detailed pathophysiological understanding with rapid technological advances. In the heterogenous area of chronic kidney disease there ...

Source: separationsNOW
Published: 11 Feb 2019

Dr. Sweis on the Management of TKI-Associated Adverse Events in Kidney Cancer

Randy F. Sweis, MD, instructor of medicine, University of Chicago Medicine, discusses the management of TKI-associated adverse events in kidney cancer. The adverse events associated with TKIs are very distinct from immunotherapy, says Sweis, and they ...

Source: OncLive.com
Published: 14 Feb 2019

Tissue match on genome-wide level leads to longer preservation of kidney graft

The conformance of genetic characteristics is essential for the long-term function after kidney transplantation ... Therefore, in the spirit of personalised medicine, the aim is always to achieve ...

Source: Medical Xpress
Published: 15 Feb 2019

Marshall School of Medicine professor earns ASPET for career achievements

Edwards School of Medicine, has been named the recipient of the 2019 Career ... He has also examined the role of halogens in the renal damage mediated by aniline, aminophenol and nitrobenzene compounds, which are intermediates in the production of drugs ...

Source: EurekAlert!
Published: 12 Feb 2019

Nuclear Medicine/Radiopharmaceuticals Market Prospects & Upcoming Trends and Opportunities Upto 2023

the mechanism process of kidney cells. The radiopharmaceuticals helps in diagnosing metal health of the patients and it also helps in diagnosing the exact location of bone fracture and the cancers location. Nuclear Medicine/Radiopharmaceuticals Market ...

Source: Digital Journal
Published: 13 Feb 2019

Hunt for immunotherapy combinations turns up success in kidney cancer

in an editorial published Saturday in the New England Journal of Medicine. The two trials enrolled previously untreated patients with metastatic renal cell carcinoma, the most prevalent form of kidney cancer. Renal cell carcinoma is considered the third ...

Source: BioPharma Dive
Published: 16 Feb 2019

Modest NSAID Usage in Working Age Adults Linked to Greater Risk of Kidney Disease

Clinicians are generally most concerned about the effects of these medications on the kidneys among patients with existing renal impairment and persons ... team at the Stanford University School of Medicine, and do not represent the position of the United ...

Source: Medicalresearch.com
Published: 16 Feb 2019

Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study

Corresponding Author: April Jorge, MD, Instructor in Medicine, Division of Rheumatology ... To assess the potential effect on survival of renal transplant among patients with ESRD due to LN (LN-ESRD) in the United States. First renal transplant was ...

Source: Annals.org
Published: 21 Jan 2019